(S)-2-Hydroxy-3-(1H-indol-3-yl)propanoic acid

Catalog No. :
ACXFPA512
CAS No. :
7417-65-4
Molecular Formula :
C11H11NO3
Molecular Weight :
205.21

IUPAC Name:(S)-2-hydroxy-3-(1H-indol-3-yl)propanoic acid

(S)-2-Hydroxy-3-(1H-indol-3-yl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$271.00Login to see priceIn stockInquiry
100mg95%$407.00Login to see priceIn stockInquiry
250mg95%$817.00Login to see priceIn stockInquiry
1g95%$2022.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-Hydroxy-3-(1H-indol-3-yl)propanoic acid
IUPAC Name(S)-2-hydroxy-3-(1H-indol-3-yl)propanoic acid
MDL No.MFCD09839710
Molecular FormulaC11H11NO3
Molecular Weight205.21
SMILESO=C(O)[C@@H](O)CC1=CNC2=C1C=CC=C2
InChI KeyXGILAAMKEQUXLS-JTQLQIEISA-N
Synonym(S)-2-hydroxy-3-(1H-indol-3-yl)-propionic acid;1H-Indole-3-propanoicacid,-alpha--hydroxy-,(-alpha-S)-(9CI);(2S)-2-Hydroxy-3-indoylpropanoic acid;L-3-(3-Indolyl)lactic acid;L-Indole-3-lactic acid;(S)-2-hydroxy-3-(1H-indol-3-yl)propanoic acid;1H-Indole-3-propanoic acid, α-hydroxy-, (αS)-;1H-Indole-3-propanoic acid, alpha-hydroxy-, (alphaS)-
CAS No.7417-65-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACXFPA512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUDOF243 route compound structure diagram
    ACUDOF243392-12-1 In Stock
  2. Then
  3. ACXFPA512 route product structure diagram
    ACXFPA5127417-65-4 In Stock
Inquiry

2. ACXFPA512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXFPA512 route product structure diagram
    ACXFPA5127417-65-4 In Stock
Inquiry

Comments (0)